emerging infectious disease

Mpox—The Latest Zoonotic Virus Making Headlines

Posted on by Kelly Grooms

Mpox (formerly known as Monkeypox; 1) has been making the news lately. The declaration by the WHO Director-General naming mpox a public health emergency of international concern (PHEIC; 2) has a lot of people wondering what it is, how it spreads and how concerned they should be. Understandably, we are all a little jumpy when we start hearing about a new viral disease, but the virus that causes mpox (monkeypox virus) isn’t new.

Artists rendering of monkeypox on a torso.

A member of the Poxviridae family, the monkeypox virus is closely related to the variola virus that causes smallpox; however, monkeypox causes milder symptoms and is less fatal (1). While the virus gained its unfortunate name from its discovery in monkeys in 1958 (3), the original source of the disease remains unknown. The virus exists in a wide range of mammals including rodents, anteaters, hedgehogs, prairie dogs, squirrels and shrews (4) and can spread to humans through close contact with an infected individual or animal. Symptoms can include fever, headache, muscle and back pain, swollen lymph nodes, chills and exhaustion (3). The most distinguishing symptom is the blister-like rash.

Continue reading “Mpox—The Latest Zoonotic Virus Making Headlines”

From Drug Use to Viral Outbreaks, How Monitoring Sewage Can Save Lives

Posted on by Johanna Lee

Most of us, after we flush the toilet, don’t think twice about our body waste. To us, it’s garbage. To epidemiologists, however, wastewater can provide valuable information about public health and help save lives.

History of Wastewater-Based Epidemiology

Wastewater-based epidemiology (WBE) is the analysis of wastewater to monitor public health. The term first emerged in 2001, when a study proposed the idea of analyzing wastewater in sewage-treatment facilities to determine the collective usage of illegal drugs within a community. At the time, this idea to bridge environmental and social sciences seemed radical, but there were clear advantages. Monitoring wastewater is a nonintrusive and relatively inexpensive way to obtain real-time data that accurately reflects community-wide drug usage while ensuring the anonymity of individuals.

Continue reading “From Drug Use to Viral Outbreaks, How Monitoring Sewage Can Save Lives”

Bartonella sp. and Your Cat (or Dog, Horse, Rat): An Emerging Infectious Disease

Posted on by Kari Kenefick

If we’ve learned nothing else since February or March of 2020, we’ve learned that emerging infectious diseases are a real threat to human health globally. In a bad news/good news kind of way, Bartonellosis is an emerging infectious disease; however, it’s not spread by airborne droplets or respiration.

But if any of your family pets bring a flea or tick into the house, or if you live in proximity to mice, rats, ground squirrels, rabbits, sheep, horses or cattle–you could be at risk.

Bartonella sp. is a Gram negative, rod-shaped bacteria that has been around since ancient times. It’s the bacteria responsible for cat scratch disease (1) and for Trench fever (2), which affected soldiers during WWs I and II, and affects people living in over-crowded, unsanitary conditions around the world today.

Bartonella henselae bacteria, the causative agent of cat-scratch disease or bartonellosis,. 3D illustration
Bartonella henselae bacteria, the causative agent of cat-scratch disease or bartonellosis

Bartonella sp. are known to be spread by vectors such as fleas, which are part of the transmission cycle for cat scratch disease and the human body louse, the vector for transmission of Trench fever (3).

This animal-to-human transmission of Bartonella sp. classifies it as a zoonosis.

Infection due to Bartonella sp. often appear to be self-limiting, such as swelling in regional lymph nodes due to a cat scratch disease. In such cases, symptoms can subside without intervention. But Bartonella sp. have a nasty habit of hiding in red blood cells and in cells lining blood vessels, where they can remain undetected for a substantial period of time. This hiding place affects a host’s ability to mount an immune response, as well as affecting the ability of antibiotics to attack the bacteria.

Continue reading “Bartonella sp. and Your Cat (or Dog, Horse, Rat): An Emerging Infectious Disease”

The Race to Develop New Therapeutics Against Coronaviruses

Posted on by Michele Arduengo

Once the purview of virology researchers, the word “coronavirus” is now part of the vernacular in the mainstream media as reports of quarantined cruise ships (1) and makeshift hospitals (2) fill our online news feeds. While there is currently no approved anti-viral treatment for coronavirus infection (3), a team led by researchers from Vanderbilt University recently published work characterizing the anti-CoV activity of a compound, which they now plan to test against 2019-nCoV (4).

Developing New Therapeutics Against Coronaviruses

Coronaviruses (CoVs) are enveloped, single-stranded RNA viruses that exhibit cross-species transmission—the ability to spread quickly from one host (e.g., civet) to another (e.g., human). Scientists classify CoVs into four groups based on the nature of the spikes on their surface: alpha (α), beta (ß), gamma (γ) and delta (δ, 1). Only the alpha- and beta-CoVs can infect humans. Four coronaviruses commonly circulate within human populations: Human CoV 229E (HCoV229E), HCoVNL63, HCoVOC43, and HCoVHKU1. Three other CoVs have emerged as infectious agents, jumping from their normal animal host species to humans: SARS-CoV, MERS-CoV and most recently, 2019-nCoV (5).

TE micrograph of a single MERS-CoV
Digitally colorized transmission electron micrograph reveals ultrastructural details of a single Middle East respiratory syndrome coronavirus (MERS-CoV) virion. Image credit: National Institute of Allergy and Infectious Diseases

The need for an effective, broad spectrum treatment against HCoVs, has been brought into sharp focus by the recent outbreak of the 2019 Novel Coronavirus (2019-nCoV; 6).

Continue reading “The Race to Develop New Therapeutics Against Coronaviruses”